Liquidia Corporation.
LQDA.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of novel products that address unmet needs in pulmonary hypertension and other applications. The company utilizes its proprietary PRINT® technology to create precisely engineered drug particles desig...Show More
Better Health for All
-50
Liquidia Corporation's core business is dedicated to developing and commercializing FDA-approved treatments for rare cardiopulmonary diseases like pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), which have no cure.
1
Their products, such as YUTREPIA and generic Treprostinil Injection, aim to improve exercise ability and quality of life, with the generic offering a lower-cost alternative.
2
The company's Morrisville facility received no FDA Form 483 Inspectional Observations in August 2021.
3
However, YUTREPIA's list price is $24,360 for a 28-day supply, and a voucher program offers only a one-time, 28-day free supply.
4
The company faces ongoing patent infringement litigation from United Therapeutics, which seeks to block YUTREPIA's commercialization.
5
Risk disclosures indicate that once medical information is shared with the sponsor or government agencies, it may no longer be protected by US federal privacy regulations.
6
Data collected prior to withdrawal of authorization may still be processed, and long-term health status may be obtained from public sources.
7
The company's data handling practices involve sharing coded medical information with numerous third parties and transferring data to other countries for processing, with storage for a minimum of 25 years.
8
Liquidia invests in clinical development for YUTREPIA and L606, utilizing its PRINT® technology for drug particle engineering.
9
Most common adverse reactions for YUTREPIA include cough, headache, throat irritation, and dizziness (≥10%).
10
Fair Money & Economic Opportunity
0
Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing drug products.
1
The provided articles discuss drug pricing, patient support programs for medication access, corporate financial performance, and shareholder information. There is no evidence that the company offers lending, deposit, insurance, or other financial services to consumers. Therefore, KPIs related to financial products, services, or customer financial data are not applicable. The company's patient support services and drug pricing are not relevant to the financial services context of this value.
Fair Pay & Worker Respect
0
71% of employees would recommend working at Liquidia Technologies.
1
Employee ratings on Glassdoor include an overall rating of 3.6 out of 5 stars (based on 22 reviews), a Compensation and Benefits rating of 3.7 out of 5, a Culture & Values rating of 3.8 out of 5, and a Work/Life Balance rating of 3.8 out of 5.
2
Additionally, 69% of employees approve of the CEO.
3
Fair Trade & Ethical Sourcing
0
No specific, concrete data points were found in the provided articles to assess Liquidia Corporation against any of the Fair Trade & Ethical Sourcing KPIs. Information regarding fair-trade certification, audit frequency, forced/child labor incidents, supply chain traceability, remediation speed, ethical clause coverage, materials risk index, or supplier diversity spend was not available or not applicable to the company as a whole. While one article detailed a supply agreement with a single supplier,
1
it did not provide company-wide or quantifiable data for any of the defined KPIs.
Honest & Fair Business
0
No specific, quantifiable data relevant to the 'Honest & Fair Business' ethical value was found in the provided articles. While Liquidia Corporation is under investigation for potential securities law violations, no specific fines or regulatory actions have been mentioned or reported as an outcome of this investigation.
1
Kind to Animals
0
The company is a biopharmaceutical firm
1
, and its business model does not involve animal agriculture or the sourcing of animal products like eggs, meat, or dairy.
2
Therefore, the KPIs related to cage-free sourcing and animal agriculture ethics are not applicable.
3
While one article mentions that "preclinical studies" and "animal studies" are required by the FDA for drug development, no specific, concrete data points were provided regarding the company's animal testing policy, the volume of animals used, the extent of alternative testing methods employed, cruelty-free certifications, or any wildlife conservation initiatives.
4
No War, No Weapons
0
Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing products for pulmonary hypertension and other applications. The provided articles contain no evidence of the company deriving revenue from arms or defense contracts, nor do they indicate any involvement in defense or arms-related activities in its core business.
1
Therefore, the KPI 'revenue_arms_contracts' is scored as N/A.
Planet-Friendly Business
0
No specific, quantifiable data points were found in the provided articles to assess Liquidia Corporation against the 'Planet-Friendly Business' KPIs. The articles primarily consist of financial reports (Form 10-Q, 10-K)
1
,
2
and general ESG rating summaries
3
,
4
,
5
, which do not contain details on environmental performance metrics such as emissions, renewable energy use, waste diversion, water consumption, or climate targets. While one article mentioned compliance with ISO7 clean room standards and cGMP air quality requirements for a manufacturing facility
6
, and that an FDA inspection in August 2021 concluded with no observations
7
, this information is not sufficient to score annual, company-wide KPIs like 'pct_buildings_green_certified' or 'annual_env_compliance_violations'.
Respect for Cultures & Communities
0
No specific, quantifiable evidence was found across the provided articles for any of the KPIs related to 'Respect for Cultures & Communities'. The articles primarily consist of a proxy statement, cookie policies, employee benefits information, and a code of conduct. While the code of conduct mentions a general responsibility to the community and an ethics hotline, it does not provide specific data on community-focused grievance mechanisms, partnerships, investments, or other metrics required by the rubric.
1
The available information does not allow for scoring against the defined quantitative thresholds.
Safe & Smart Tech
0
Liquidia Corporation is subject to ongoing regulatory requirements for manufacturing, labeling, advertising, and post-market information.
1
The company and its partners process sensitive data and are subject to data privacy and security obligations.
2
Zero Waste & Sustainable Products
0
Liquidia Corporation is subject to environmental and health and safety laws and regulations that govern laboratory processes and the handling, use, storage, treatment, and disposal of hazardous materials and waste.
1
The company states that failure to comply with these regulations may result in significant liability.
2